Literature DB >> 8816313

The total cost of hip-joint replacement; a model for purchasers.

P B Pynsent1, S R Carter, C J Bulstrode.   

Abstract

A computer-based model is used to investigate the total cost of primary total hip-joint replacement. The model takes into account the probability of prosthesis failure, death and re-revision. The results emphasize the importance of age at insertion, demonstrating that the expected life-span of the patient has a major influence on the total cost for a given prosthesis. The discussion considers the idea of a 'lifetime care package' to encapsulate the concept of quality when considering the purchasing of total hip replacements. If it is assumed that a primary replacement episode costs 3500 pounds and revision surgery costs twice as much, then the additional premium on the best implant currently available would be 630 pounds. The premium payable on the same patient using the worst design would be 3080 pounds. This difference reflects the importance of quality in total hip replacement surgery.

Entities:  

Mesh:

Year:  1996        PMID: 8816313     DOI: 10.1093/oxfordjournals.pubmed.a024475

Source DB:  PubMed          Journal:  J Public Health Med        ISSN: 0957-4832


  4 in total

1.  An economic model to estimate the relative costs over 20 years of different hip prostheses.

Authors:  K Baxter; G Bevan
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

2.  How long should patients be followed-up after total hip replacement? Current practice in the UK.

Authors:  M J Bankes; R Coull; B D Ferris
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

3.  Optimizing a hydroxyapatite/tricalcium-phosphate ceramic as a bone graft extender for impaction grafting.

Authors:  B Grimm; A W Miles; I G Turner
Journal:  J Mater Sci Mater Med       Date:  2001 Oct-Dec       Impact factor: 3.896

4.  Can choices between alternative hip prostheses be evidence based? a review of the economic evaluation literature.

Authors:  Charlotte Davies; Paula Lorgelly; Ian Shemilt; Miranda Mugford; Keith Tucker; Alex Macgregor
Journal:  Cost Eff Resour Alloc       Date:  2010-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.